Compare MED & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MED | STIM |
|---|---|---|
| Founded | 1980 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 120.6M | 105.5M |
| IPO Year | N/A | 2018 |
| Metric | MED | STIM |
|---|---|---|
| Price | $11.12 | $1.98 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $16.50 | $7.00 |
| AVG Volume (30 Days) | 316.0K | ★ 1.4M |
| Earning Date | 02-17-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $429,695,000.00 | $129,873,000.00 |
| Revenue This Year | N/A | $101.67 |
| Revenue Next Year | N/A | $10.87 |
| P/E Ratio | $535.71 | ★ N/A |
| Revenue Growth | N/A | ★ 78.61 |
| 52 Week Low | $10.10 | $1.25 |
| 52 Week High | $17.62 | $5.92 |
| Indicator | MED | STIM |
|---|---|---|
| Relative Strength Index (RSI) | 49.16 | 66.17 |
| Support Level | $10.50 | $1.34 |
| Resistance Level | $11.14 | $1.50 |
| Average True Range (ATR) | 0.44 | 0.16 |
| MACD | -0.02 | 0.08 |
| Stochastic Oscillator | 44.78 | 91.89 |
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.